AzTrials
AzTrials

Quality of LifeNCT05704179

Evaluation of the Relationship Between Obstetric Comorbidity Index and Obstetric Quality of Recovery Score

An observational study of Quality of Life and Obstetric Complication, run by Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of this prospective observational study is to learn about the correlation between obstetric comorbidity index and obstetric quality of recovery score in pregnant patients who undergo cesarean section. Read more about this study

Who is it for?
Ages 18 years and older, women onlyHealthy volunteers can take part
What is being tested?
Obstetric Quality of recovery score
How many people
214 participants
Where
1 siteTurkey (Türkiye)
Study dates
20 Jan 2023to 20 Mar 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Turkish or English-speaking, >18 years old, pregnant patients who undergo cesarean section will be included in the study.

Who may be able to join

  • Pregnant women who are admitted for Cesarean section > 18 years old
  • Speaking Turkish or English
  • Agreeing to participate in the study

Who cannot join

  • Pregnant women < 18 years old
  • Can not speak Turkish or English
  • Not agreeing to participate in the study

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Prof. Dr. Cemil Taşçıoğlu Training and Research Hospital

    Istanbul, 0 (538) 314-55-

Other trials in Turkey (Türkiye)

About this study

Official title: Evaluation of the Relationship Between Obstetric Comorbidity Index and Obstetric Recovery Quality Score in Patients Who Undergo Operative Delivery

The goal of this prospective observational study is to learn about the correlation between obstetric comorbidity index and obstetric quality of recovery score in pregnant patients who undergo cesarean section. The main question aims to answer are:

  • Are there a correlation between the obstetric comorbidity index and the obstetric quality of recovery score? Can we predict the postoperative quality of recovery by calculating the obstetric comorbidity index before delivery?
  • What is the relationship between these scores with the type of anaesthesia given? Participants will answer an 11-question assessment scale to evaluate their recovery of quality in the postpartum period.
Read the detailed description

After the approval of the ethics committee and the written informed consent of the patients, the patients who are meeting the criteria of inclusion will be included in the study. The demographic data, type of anaesthesia, intraoperative haemorrhage, length of hospital stay and intensive care unit stay(if applicable), the urgency category of the cesarean section, and complications will be recorded. patients will be evaluated with obstetric quality of recovery assessment score on postpartum 1st and 2nd days

Being tested
Obstetric Quality of recovery score
Keywords
Obstetric comorbidity index, Obstetric Quality of Recovery, Cesarean section, Obstetric Anaesthesia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Obstetric Quality of recovery scoreOther

    Patients' quality of recovery will be evaluated with Obstetric Quality of recovery score (ObsQoR-11) on postpartum day 1 and day 2.

Study groups in NCT05704179
Study groupRoleWhat they receive
Patients who undergo cesarean sectionObstetric comorbidity index will be calculated for all patients, obstetric quality of recovery score will be evaluated in postpartum period( on the first and second day postpartum)
Receives: Other: Obstetric Quality of recovery score

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The correlation between Obstetric comorbidity index (OBCMI) and Obstetric Quality of Recovery score(ObsQoR-11) on postpartum 1st day

    Obstetric comorbidity index will be calculated before c-section.ObsQoR-11 Questionnaire will be done postoperatively.

    Measured: each patient will be evaluated on postpartum 1st day

  2. The correlation between Obstetric comorbidity index (OBCMI) and Obstetric Quality of Recovery score(ObsQoR-11) on postpartum 2nd day

    Obstetric comorbidity index will be calculated before c-section.ObsQoR-11 Questionnaire will be done postoperatively.

    Measured: each patient will be evaluated on postpartum 2nd day

Secondary outcomes (20)
  1. Evaluation of the relationship between type of anaesthesia and OBCMI

    Type of anaethesia will be recorded from the anaesthesia follow-up sheats. Obstetric comorbidity index will be calculated before c-section.

    Measured: each patient will be evaluated on the day of c-section

  2. The relation between Lenght of hospital stay and ObsQoR-11 score on postpartum 1st day

    Lenght of hospital stay will be recorded from hospital software.ObsQoR-11 will be evaluated on postpartum 1st day

    Measured: 2months

  3. The relation between Lenght of hospital stay and ObsQoR-11 score on postpartum 2nd day

    Lenght of hospital stay will be recorded from hospital software. ObsQoR-11 will be evaluated on postpartum 2nd day

    Measured: 2months

  4. The relation between complications and OBCMI

    Complications will be recorded.

    Measured: 2months

  5. The relation between complications and ObsQoR-11 on postpartum 1st day

    Complications will be recorded

    Measured: 2months

  6. The relation between complications and ObsQoR-11 on postpartum 2nd day

    Complications will be recorded

    Measured: 2months

  7. The relation between urgency of cesarean section and OBCMI

    C-section category will be evaluated

    Measured: each patient will be evaluated on the day of c-section

  8. The relation between urgency of cesarean section and ObsQoR-11 score on postpartum 1st day

    C-section category will be evaluated

    Measured: each patient will be evaluated on the day of c-section

  9. The relation between urgency of cesarean section and ObsQoR-11 score on postpartum 2nd day

    C-section category will be evaluated

    Measured: each patient will be evaluated on the day of c-section

  10. The relation between intraoperative hemorrhage and OBCMI

    Instraoperative hemorrhage will be recorded from the anaesthesia follow-up sheats.

    Measured: On the day of C-section

  11. The relation between intraoperative hemorrhage and ObsQoR-11 score on postpartum 1st day

    Instraoperative hemorrhage will be recorded from the anaesthesia follow-up sheats.

    Measured: On the day of C-section

  12. The relation between intraoperative hemorrhage and ObsQoR-11 score on postpartum 2nd day

    Instraoperative hemorrhage will be recorded from the anaesthesia follow-up sheats.

    Measured: The first 2 days postpartum

  13. The relation between postoperative intensive care unit stay and OBCMI

    Postoperative intensive care unit need and lenght of stay will be recorded

    Measured: each patient will be evaluated on the day of c-section

  14. The relation between postoperative intensive care unit stay and ObsQoR-11 score on 1st day

    Postoperative intensive care unit need and lenght of stay will be recorded.

    Measured: each patient will be evaluated on postpartum 1st day

  15. The relation between postoperative intensive care unit stay and ObsQoR-11 score on 2nd day

    Postoperative intensive care unit need and lenght of stay will be recorded.

    Measured: each patient will be evaluated on postpartum 2nd day

  16. Demographic data, previous obstetric history and their relation with OBCMI

    Demographic data and previous obstetric history will be recorded in preoperative assessment

    Measured: On the day of C-section

  17. Demographic data, previous obstetric history and their relation with ObsQoR-11 score on postpartum 1st day

    Demographic data and previous obstetric history will be recorded in preoperative assessment

    Measured: Postpartum 1st day

  18. Demographic data, previous obstetric history and their relation with ObsQoR-11 score on postpartum 2nd day

    Demographic data and previous obstetric history will be recorded in preoperative assessment

    Measured: Postpartum 2nd day

  19. Evaluation of the relationship between type of anaesthesia and ObsQoR-11 score on postpartum 1st day

    Type of anaethesia will be recorded from the anaesthesia follow-up sheats. ObsQoR-11 will be evaluated on postpartum 1st day

    Measured: each patient will be evaluated on postpartum 1st day

  20. Evaluation of the relationship between type of anaesthesia and ObsQoR-11 score on postpartum 2nd day

    Type of anaethesia will be recorded from the anaesthesia follow-up sheats. ObsQoR-11 will be evaluated on postpartum 2nd day

    Measured: each patient will be evaluated on postpartum 2nd day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Jan 2023
  2. Study start20 Jan 2023
  3. Primary completion20 Mar 2023
  4. Study completion20 Mar 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
214 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05704179
Sponsor's protocol ID
23052022162
Status last verified
Feb 2024
First submitted
14 Nov 2022
Last updated
14 Feb 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Ciechanowicz S, Setty T, Robson E, Sathasivam C, Chazapis M, Dick J, Carvalho B, Sultan P. Development and evaluation of an obstetric quality-of-recovery score (ObsQoR-11) after elective Caesarean delivery. Br J Anaesth. 2019 Jan;122(1):69-78. doi: 10.1016/j.bja.2018.06.011. Epub 2018 Jul 31.

    PubMed 30579408
  • Bateman BT, Mhyre JM, Hernandez-Diaz S, Huybrechts KF, Fischer MA, Creanga AA, Callaghan WM, Gagne JJ. Development of a comorbidity index for use in obstetric patients. Obstet Gynecol. 2013 Nov;122(5):957-965. doi: 10.1097/AOG.0b013e3182a603bb.

    PubMed 24104771
  • Easter SR, Bateman BT, Sweeney VH, Manganaro K, Lassey SC, Gagne JJ, Robinson JN. A comorbidity-based screening tool to predict severe maternal morbidity at the time of delivery. Am J Obstet Gynecol. 2019 Sep;221(3):271.e1-271.e10. doi: 10.1016/j.ajog.2019.06.025. Epub 2019 Jun 20.

    PubMed 31229427

Questions about this trial

What is this clinical trial studying?

An observational study of Quality of Life and Obstetric Complication, run by Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 14 Feb 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The correlation between Obstetric comorbidity index (OBCMI) and Obstetric Quality of Recovery score(ObsQoR-11) on postpartum 1st day (time frame: each patient will be evaluated on postpartum 1st day). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05704179, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Feb 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in